Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.06M | 2.11M | 1.63M | 1.55M | 1.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.02M | 3.02M | 2.51M | 2.50M | 2.62M |
| Operating Income | -3.02M | -3.02M | -2.51M | -2.50M | -2.62M |
| Income Before Tax | -3.38M | -3.26M | -3.37M | -3.04M | -2.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.38 | -3.26 | -3.37 | -3.04 | -2.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.38M | -3.26M | -3.37M | -3.04M | -2.28M |
| EBIT | -3.02M | -3.02M | -2.51M | -2.50M | -2.62M |
| EBITDA | -2.74M | -2.68M | -2.08M | -2.06M | -2.21M |
| EPS Basic | -0.16 | -0.16 | -0.17 | -0.15 | -0.11 |
| Normalized Basic EPS | -0.10 | -0.10 | -0.10 | -0.10 | -0.07 |
| EPS Diluted | -0.16 | -0.16 | -0.17 | -0.15 | -0.11 |
| Normalized Diluted EPS | -0.10 | -0.10 | -0.10 | -0.10 | -0.07 |
| Average Basic Shares Outstanding | 83.75M | 82.11M | 80.48M | 80.00M | 80.00M |
| Average Diluted Shares Outstanding | 83.75M | 82.11M | 80.48M | 80.00M | 80.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |